An interventional study of running on a treadmill under normoxia or hypoxia in Healthy Men and Women, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-02.
Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Basic science
Among 35 studies in Hypoxia with a site in Germany — 4 open to participants now, 4 under way, 1 of them phase 3. Hypoxia · Germany.
Among the 35 studies in Hypoxia with a site in Germany, this one is the 17th largest by enrollment of the 30 interventional ones that give a count, is the only one that started in 2016, is one of 22 with no phase, and was the 22nd registered.
1,076 studies on the registry are indexed under Hypoxia; 213 are open to participants now.
Browse Hypoxia studies →4 of the 35 studies in Hypoxia with a site in Germany are open now. Recruiting first, the newest first:
Schön Klinik Berchtesgadener Land · Sites in Germany
Australian and New Zealand Intensive Care Research Centre · Sites in Germany, Australia
University of Giessen · Sites in Germany
Technical University of Munich · Sites in Germany
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 125 Hypoxia studies recruiting now, 53 (42%) set no upper age limit and 45 (36%) stop at 75 or younger; 15 take children under 18; 33 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
35 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 6
First in 2003; this study’s year is marked. 1 started in 2016.
This study's enrollment of 34 is below the median of 45 across 769 interventional studies indexed under Hypoxia.
Median enrollment 35 across the 30 interventional studies, 140 across the 4 observational. Of the 27 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 35 has an industry lead sponsor. The 10 most frequent:
Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 129 are open to participants now.
Charite University, Berlin, Germany has 3 studies filed under Hypoxia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 35 studies in Hypoxia with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to systematically Analyse the metabolome in capillary blood of healthy men and women at rest and during defined standardized physical activity under normobaric normoxia or hypoxia with a specific focus on metabolites and metabolic pattern related to energy metabolism. The metabolome analyses in capillary blood could give us also or more detailed insight into erythrocyte metabolic physiology because it is known for a longer time that the primary metabolism of the erythrocyte reflects its Oxygen Saturation via the glycolytic metabolites / intermediates pattern.
1,076 studies on the registry are indexed under Hypoxia; 213 are open to participants now.
This study's enrollment of 34 is below the median of 45 across 769 interventional studies indexed under Hypoxia.
Browse Hypoxia studies →Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 129 are open to participants now.
Compared within Hypoxia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
running under hypoxia (first day) and normoxia (second day)
Other: running on a treadmill under normoxia or hypoxia
running under normoxia (first day) and hypoxia (second day)
Other: running on a treadmill under normoxia or hypoxia
* 30 min running (60% VO2max) on a treadmill under hypoxia (O2: 14%) * 30 min running (60% VO2max) on a treadmill under normoxia (O2: 20%)
Change in capillary lactate/pyruvate Ratio (dimension-free)
marker for the ratio between anaerobic / aerobic glycolysis
Time frame: t = 0 min (before exercise); t = 10, 20 and 30 min during exercise; t = 50 and 60 min during recovery
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2016 to primary completion in Mar 2017, 7 months.
Of 321 non-industry interventional studies with no phase under Hypoxia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's 7 months is below that.
Counting every sponsor, half of 351 studies reached it within 12 months; a quarter within 3 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →